Skip to main content
U.S. Department of Health & Human Services Health Resources & Services Administration
Explore
  • Bureaus and Offices
  • Newsroom
  • A-Z Index
  • Contact HRSA
Blood Stem Cell
  • Home
    • Overview
    • About Transplantation
    • Planning for a Transplant
    • Searching for a Match
    • Patient Support
    • Physician Resources
    • Overview
    • Donate Bone Marrow
    • Donate Cord Blood
    • Cord Blood Units for Research
    • Overview
    • Donation and Transplantation Statistics
    • About Data
    • Request and Cite Data
    • Overview
    • FAQs
    • Advisory Council
    • Legislation
    • Contracts
    • Radiation Injury Treatment Network
    • Content Inventory
Search
  • FAQs
  • Sitemap

Breadcrumb

  1. Home
  2. About
  3. Advisory Council on Blood Stem Cell Transplantation
  4. September 10, 2019

September 10, 2019

Agenda
Agenda (PDF - 160.29 KB)
Presentations
Innovation Lab Improve Cord Blood Experience & Payor Policy Highlights (PDF - 1.55 MB)
Challenges Resulting from Implementing Donor Screening Recommendations to Reduce Risk of Zika Transmission: Background (PDF - 2.54 MB)
Cord Blood Consultation Service (PDF - 93.51 KB)
Efforts to Increase Cord Blood Utilization (PDF - 2.29 MB)
The Diverse Use of Cord Blood for Hematologic & Non-Hematologic Indications (PDF - 2.09 MB)
Key Takeaways Physician Cord Blood Summit (PDF - 110.86 KB)
Report Overview (PDF - 2.8 MB)
The Impact of Current Policies for Zika Virus Screening on Accrual to the Carolinas Cord Blood Bank (PDF - 427.28 KB)
Update on the Current Status of Zika Virus Epidemiology (PDF - 229.05 KB)
Impact of ZIKA virus (ZIKV) risk on public Cord Blood Banking (PDF - 1.41 MB)
Screening of Cord Blood Donors for Zika Virus Infection (PDF - 2.2 MB)
Meeting Summary
Meeting Summary Notes (PDF - 343.4 KB)

Recommendations

Recommendation 32

Based on current data and reduction in observed and confirmed Zika infection, ACBSCT recommends that HHS review the current FDA Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components as the guidance relates to utilization of cord blood. 

Accessibility Disclaimer
Persons using assistive technology may not be able to fully access information in these files. For assistance, contact comments@hrsa.gov or 888-275-4772 (TTY: 877-489-4772).
Return to top
Be a Hero. Register today and save someone’s life.
Join the Registry HRSA Exit Disclaimer

More About the Program

  • Advisory Council
  • Content Inventory
  • Contracts
  • Legislation
  • Reports to Congress
HRSA Health Resources and Services Administration
Facebook Twitter YouTube LinkedIn Instagram
AskBSCT@hrsa.gov

Helpful Links

  • Accessibility
  • Disclaimers
  • Freedom of Information Act
  • Health and Human Services
  • No FEAR Act
  • Privacy Policy
  • Viewers & Players
  • Vulnerability Disclosure Policy
  • USA.gov
  • WhiteHouse.gov

Language Assistance

  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • Kreyòl Ayisyen
  • Polski
  • Português
  • Tagalog
  • Tiếng Việt
  • Русский
  • العربية
  • فارسی
  • 日本語
  • 繁體中文
  • 한국어